“…The sensitivity and reproducibility of in situ hybridization has previously been well characterized (Williams, 1982;Downs and Williams, 1984;Stolz et al, 1989). mRNA expression was measured by in situ hybridization using subclones that were generated by amplifying unique segments of 2′,3′-cyclic nucleotide 3′-phosphodiesterase (Abbreviation: CNP, Genebank accession number: NM_03313, region used for probe: 523-1066), myelinassociated glycoprotein (MAG, XM_01287, 305-835), transferrin (TF, XM_00279, 1172-1940, quaking (QKI, AF142421, 508-715), gelsolin (GSN, XM_01654, 1249-1649, myelin oligodendrocyte glycoprotein (MOG, U18800, 109-263), v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (ErbB3, NM_00198, 3081-3325), erbb2 interacting protein (ErbB2IP, NM_01869, 3531-3858), motility-related protein-1 (CD9, M38690, 330-666), SRY-box containing gene 10 (SOX10, BL007595, 1337-1560), oligodendrocyte transcription factor 2 (OLIG2, NM_00580, 423-628), peripheral myelin protein 22 (PMP22, BC019040, 293-637), and Claudin-11 (CLDN11, NM_00560, 610-821) from a human cDNA brain library (Human Adult Brain Unamplified cDNA Library, Edge Biosystems; Gaithersburg, MD) and Polymerase Chain Reaction (PCR).…”